Thursday, February 24, 2022 11:52:56 AM
Pre-whine, obfuscate? Flip/short/personal agenda issues? For some.
UK Stroke clinical trial approvals thru MHRA, Due.
CC/IPF readouts expected in 2nd Q. The long trial may benefit results from the IPF portion, IMO.
Ifenprodil cancer tumor treatment, non dilutive funding / other - interest - support.?. Possible Successful Cancer tumor treatment IS a Big deal.
Probably ALL Prior to an uplist to the Nasdaq. IMO...
Progress on the new CKD initiative and more progress on Some/ALL of the above items, probably immediately before the uplist.
'the right time'
Prospectus conditional on Nasdaq uplist. 2/1 + for Longs/friends/family on Nasdaq move.?.
$2M, on hand. probably less. No immediate need for large cash outflow unless successes in some of these initiatives.
Probably no CT in Rumania or the Ukraine. JMHO...GLTA...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM